SCHEMBL30833424

SCHEMBL30833424

Cn1cc(NC(=O)N2CCCCC2C(C)(F)S(=O)(=O)c2cccc(F)c2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.39
FGFR1 P11362 2/20 0.39
KDR P35968 2/20 0.39
USP2 O75604 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM1A O60341 4/20 0.39
TSHR P16473 1/20 0.39
WNT3 P56703 1/20 0.38
SFRP1 Q8N474 1/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
EPHX2 P34913 1/20 0.38
ABCC9 O60706 1/20 0.38
ABCC8 Q09428 1/20 0.38
KCNJ11 Q14654 1/20 0.38
KCNJ8 Q15842 1/20 0.38
RIPK1 Q13546 1/20 0.37
ALDH1A1 P00352 1/20 0.37
FSCN1 Q16658 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833438 0.85 NPSR1 (0.39) USP2MEN1KMT2ATSHRWNT3
SCHEMBL30833387 0.85 ABCC9 (0.41) USP2MEN1KMT2ATSHRWNT3
Trifluoroacetic Acid SCHEMBL30833404 0.83 RORC (0.40) USP2MEN1KMT2ATSHRWNT3
SCHEMBL30833426 0.83 TSHR (0.48) EGFRFGFR1KDRUSP2KMT2A
SCHEMBL17942451 0.83 TSHR (0.48) EGFRFGFR1KDRUSP2KMT2A
SCHEMBL30833388 0.82 RIPK1 (0.38) USP2MEN1KMT2AMAPTNPSR1
SCHEMBL30833383 0.80 MEN1 (0.42) USP2MEN1KMT2ATSHRWNT3
SCHEMBL17949056 0.79 TSHR (0.52) EGFRFGFR1KDRUSP2KMT2A
SCHEMBL30833449 0.77 RORC (0.42) USP2MEN1KMT2ATSHRWNT3
SCHEMBL30833386 0.77 RIPK1 (0.45) MEN1KMT2AWNT3SFRP1RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118164961-A 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-06-11 CN disclosed
CN-111393414-B 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-05-07 CN disclosed